6-(Bromomethyl)pyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACZOCD345
CAS No. :
126401-89-6
Molecular Formula :
C5H5BrN2O2
Molecular Weight :
205.01

IUPAC Name:6-(bromomethyl)pyrimidine-2,4(1H,3H)-dione

6-(Bromomethyl)pyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$65.00Login to see priceIn stockInquiry
250mg95%$129.00Login to see priceIn stockInquiry
1g95%$341.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Bromomethyl)pyrimidine-2,4(1H,3H)-dione
IUPAC Name6-(bromomethyl)pyrimidine-2,4(1H,3H)-dione
MDL No.MFCD16656956
Molecular FormulaC5H5BrN2O2
Molecular Weight205.01
SMILESO=C1NC(C=C(CBr)N1)=O
InChI KeyQKFCIPPOTNXGCH-UHFFFAOYSA-N
Synonym2,4(1H,3H)-PyriMidinedione, 6-(broMoMethyl)-;6-BroMoMethyl-1H-pyriMidine-2,4-dione;6-(BroMoMethyl)pyriMidine-2,4(1H,3H)-dione;6-(bromomethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
CAS No.126401-89-6
PubChem CID39848582

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACZOCD345 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYXGF795 route compound structure diagram
    ACYXGF795626-48-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZOCD345 route product structure diagram
    ACZOCD345126401-89-6 In Stock
Inquiry

2. ACZOCD345 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMOBI195 route compound structure diagram
    ACMOBI19522126-44-9 In Stock
  4. Then
  5. ACZOCD345 route product structure diagram
    ACZOCD345126401-89-6 In Stock
Inquiry

Comments (0)